Chemoinformaics analysis of (10E,12E)-9-HYDROXYOCTADECA-10,12-DIENOIC ACID
| Molecular Weight | 296.451 | nRot | 14 |
| Heavy Atom Molecular Weight | 264.195 | nRig | 6 |
| Exact Molecular Weight | 296.235 | nRing | 0 |
| Solubility: LogS | -3.715 | nHRing | 0 |
| Solubility: LogP | 3.56 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 53.8034 |
| nHD | 2 | BPOL | 32.9706 |
| QED | 0.666 |
| Synth | 1.464 |
| Natural Product Likeliness | -0.879 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.024 |
| HIA | 0.003 |
| CACO-2 | -4.318 |
| MDCK | 0.0000259 |
| BBB | 0.317 |
| PPB | 0.963684 |
| VDSS | 1.765 |
| FU | 0.039036 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.939 |
| CYP2c19-inh | 0.836 |
| CYP2c19-sub | 0.876 |
| CYP2c9-inh | 0.55 |
| CYP2c9-sub | 0.705 |
| CYP2d6-inh | 0.333 |
| CYP2d6-sub | 0.789 |
| CYP3a4-inh | 0.113 |
| CYP3a4-sub | 0.528 |
| CL | 4.455 |
| T12 | 0.337 |
| hERG | 0.019 |
| Ames | 0.027 |
| ROA | 0.074 |
| SkinSen | 0.063 |
| Carcinogencity | 0.524 |
| EI | 0.98 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.553941 |